Publications en collaboration avec des chercheurs de University of Amsterdam (23)

2022

  1. Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial

    European Radiology, Vol. 32, Núm. 2, pp. 1320-1329

  2. Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

    Cancer Imaging, Vol. 22, Núm. 1

  3. Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial

    Biomedicines, Vol. 10, Núm. 5

  4. Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort

    Current Oncology, Vol. 29, Núm. 2, pp. 565-577

  5. Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial

    Journal of Cancer Research and Clinical Oncology, Vol. 148, Núm. 9, pp. 2487-2496

  6. Indications, trends, and perioperative outcomes of minimally invasive and open liver surgery in non-obese and obese patients: An international multicentre propensity score matched retrospective cohort study of 9963 patients

    International Journal of Surgery, Vol. 107

  7. Outcome of major hepatectomy in cirrhotic patients; does surgical approach matter? A propensity score matched analysis

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 29, Núm. 11, pp. 1226-1239

  8. Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma

    British Journal of Cancer, Vol. 126, Núm. 2, pp. 211-218